Case Report Open Access
Copyright ©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 15, 2004; 10(14): 2153-2155
Published online Jul 15, 2004. doi: 10.3748/wjg.v10.i14.2153
Benign nontraumatic inflammatory stricture of mid portion of common bile duct mimicking malignant tumor: Report of two cases
Chiu-Yung Ho, Tseng-Shing Chen, Full-Young Chang, Shou-Dong Lee, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, National Yang-Ming University School of Medicine, Taipei, Taiwan, China
Chiu-Yung Ho, Tao Yuang Veterans Hospital, Tao-Yuang, Taiwan, China
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Tseng-Shing Chen, Division of Gastroenterology, Department of Medicine, Taipei Veterans General Hospital, 201, Sec. 2, Shih-Pai Road, Taipei 112, Taiwan, China. tschen@vghtpe.gov.tw
Telephone: +886-2-2871-2121 Fax: +886-2-2873-9318
Received: March 6, 2004
Revised: March 12, 2004
Accepted: April 9, 2004
Published online: July 15, 2004

Abstract

Benign nontraumatic inflammatory stricture of the common bile duct (CBD) may result in obstructive jaundice, which can be misdiagnosed as a malignant tumor of the CBD preoperatively. Two cases with strictures of the mid portion of the common bile duct presenting with obstructive jaundice are reported herein. Preoperative radiological studies prompted us to confidently make the diagnosis of cholangiocarcinoma. However, the postoperative diagnosis on histological examination of the resected lesions was chronic inflammation and fibrosis. The complications of chronic duodenal ulcer are considered as the etiology of these two disorders.




INTRODUCTION

Malignant bile duct strictures are mainly the result of cancer of the ampulla of Vater, pancreas, or bile duct, and account for most patients presenting with obstructive jaundice secondary to extra-hepatic bile duct stricture. Benign non-traumatic inflammatory strictures of the extra-hepatic bile duct are extremely rare with the exception of primary sclerosing cholangitis[1-3]. Most benign strictures reported in the literature are located in the hepatic hilum[4] or distal common bile duct (CBD). Here we report two cases of benign nontraumatic inflammatory strictures of the mid portion of the CBD with painless obstructive jaundice. They were confidently diagnosed as cholangiocarcinoma by radiological studies preoperatively.

CASE REPORT
Case 1

A 70 year-old male who had a 10-year history of hypertension and type 2 diabetes mellitus was presented to our hospital. He had tea-colored urine and yellowish skin discoloration for about 2 wk. No abdominal pain or body weight loss was reported. The physical examination was unremarkable except icteric sclera. A complete blood count was within normal limits.

Serum total bilirubin/direct bilirubin (TB/DB) 5.6/2.9 mg/dL (normal 0.2-1.6/0-0.3 mg/dL), alanine aminotransferase (ALT) 127 U/L (normal 0-40 U/L), asparate aminotransferase (AST) 78 U/L (normal 5-45 U/L), alkaline phosphatase (ALK-P) 380 U/L (normal 10-100 U/L) and gamma-glutamyl transpeptidase (γ-GT) 333 U/L (normal 8-60 U/L) were noted. Abdominal sonography showed dilatation of the intrahepatic ducts and CBD. The contrast-enhanced abdominal CT scan disclosed similar findings. A PTCD tube was inserted and anterograde cholangiograms exhibited a segmental narrowing of the CBD about 2 cm below the insertion site of the cystic duct (Figure 1A). A segmental stricture about 1.5 cm in length over the CBD but below the cystic duct level and dilatation of the intrahepatic ducts were also demonstrated in the endoscopic retrograde cholangiopancreatogram (ERCP) (Figure 1B). The pancreatogram was normal. Three sets of bile fluid cytology were negative. Tumor markers CA19-9 and CEA were not elevated. A diagnosis of cholangiocarcinoma with CBD stricture was made. At surgery, stricture of the mid portion of the CBD was found. Cholecystectomy and choledocholithotomy with T-tube drainage were performed. Histological examination of the resected CBD showed chronic inflammation and fibrosis without malignant cells. No stone was detected in the gallbladder. Unfortunately, tea-colored urine and skin itching developed 3 years later. The laboratory evaluation revealed serum TB/DB 2.9/1.5 mg/dL, AST 111 U/L, ALT 125 U/L, ALK-P 427 U/L and γ-GT 676 U/L. Serum AMA, ASMA, IgG, IgM, IgA and ANA titers were within normal range. ERCP demonstrated segmental stricture of the common hepatic duct about 4 cm in length (Figure 1C) and choledochoduodenal fistula. The pancreatogram was normal. MR cholangiogram disclosed an annular mass lesion with enhancement at the proximal CBD, which caused segmental narrowing of the common hepatic duct and dilatation of the intrahepatic ducts (Figure 1D). Bile duct tumors such as cholangiocarcinoma were considered. At surgery, a firm and fixed tumor 4 cm × 3 cm in size at the CBD was palpated. The duodenal bulb was adhered to the tumor and a choledochoduodenal fistula was found. Segmental resection of the CBD, hepaticojejunostomy and enteroenterostomy, end-to-side, were performed. Histological examination of the resected CBD showed chronic cholangitis with focal atypical epithelium.

Figure 1
Figure 1 Segmental strictures of CBD demonstrated in percutaneous cholangiogram, ERCP and MR cholangiogram. A: Segmen-tal narrowing of CBD below the insertion site of cystic duct in percutaneous cholangiogram; B: Segmental stricture of CBD with dilatation of intrahepatic bile ducts demonstrated in ERCP; C: Segmental stricture of CHD demonstrated in ERCP; D: Segmental narrowing of CHD and dilatation of the intrahepatic bile ducts demonstrated in MR cholangiogram.
Case 2

A 55 year-old male without significant past medical history was admitted because of painless jaundice for 1 mo. A double-contrast barium study of the upper gastrointestinal tract 2 years earlier demonstrated chronic duodenal ulcer with bulb deformity and prepyloric constriction (Figure 2). On examination, there was only icteric sclera. A complete blood count was within normal limits. Serum TB/DB 4.2/2.5 mg/dL, ALT 404 U/L, AST 293 U/L, ALK-P 357 and γ-GT 333 U/L were noted. Abdominal sonography showed dilatation of the intrahepatic ducts and CBD. A contrast-enhanced abdominal CT scan disclosed dilatation of the intrahepatic ducts and proximal CBD associated with distention of the gallbladder. ERCP failed. The MRI revealed an annular lesion about 3.5 cm in length in the mid portion of the CBD (Figure 3). Three sets of bile fluid cytology were negative. Tumor markers CA19-9 and CEA were not elevated. A diagnosis of cholangiocarcinoma was made. The patient had a laparotomy for resection of the tumor. A tumor over the middle third portion of the CBD with thickened wall was found. No stone was detected in the gallbladder or CBD. Resection of the tumor and Roux-en-Y choledochojejunostomy, end-to-side, was then performed. However, the postoperative histological examination of the lesion showed only chronic inflammation with marked fibrosis.

Figure 2
Figure 2 Chronic duodenal disease with bulb deformity and prepyloric constriction revealed in a double-contrast barium study.
Figure 3
Figure 3 Annular lesion in the mid portion of CBD disclosed in MRI (coronal view).
DISCUSSION

The clinical presentation and preoperative radiological studies without tissue or cytological proof led us to the diagnosis of malignant bile duct strictures in these 2 cases. It has been agreed that any localized extra-hepatic bile duct obstruction coexisting with intra-hepatic bile duct dilatation should be considered as malignancies such as cancer of the ampulla of Vater, pancreas, or bile duct (cholangiocarcinoma) until proven otherwise[5]. This agreement arose because of the difficulty in obtaining a tissue diagnosis in patients with obstructive jaundice caused by a bile duct stricture. Application of improved diagnostic methods, such as thin-section spiral CT and magnetic resonance cholangiopancreatography, can potentially increase the diagnostic accuracy, but neither could reliably differentiate malignant from benign lesions[6,7]. Preoperative histological or cytological examination by means of biopsy or brush cytology was often difficult and liable to false-negative results with low sensitivity and could carry a potential risk of needle tract metastases[8-12]. The lack of a tissue or cytological evidence might result in some patients being inappropriately treated as malignant disease when a benign stricture was present and vice versa. In the study of Gerhards et al[4] a false-positive preoperative diagnosis of malignancy resulted in a 15% resection rate of benign lesions in patients with suspicious hilar strictures. Careful review of all preoperative information and radiological images of our 2 cases yielded the initial diagnosis of a CBD tumor, although post-operative pathological examination revealed only inflammation and fibrosis. The decision to undertake resection of the strictures in these 2 cases was therefore not an error of judgment. Obviously, resection of the lesion and obtaining a tissue diagnosis are still the most reliable way to rule out malignancy. Therefore, resection of a benign stricture mimicking a malignant stricture in the extra-hepatic bile duct cannot be avoided completely. However, the lack of clinical constitutional symptoms such as body weight loss or abdominal pain and elevated tumor markers may implicate the possible benign entity of the disorder.

Benign, single, non-traumatic inflammatory strictures of the biliary tracts were infrequently reported with the exception of primary sclerosing cholangitis[1-3]. Indeed, many benign nontraumatic inflammatory strictures of the common bile duct have been generally considered to be a variant of primary sclerosing cholangitis although Standfield et al[13] described 12 cases of benign strictures of unknown etiology, and differentiated them from the localized form of sclerosing cholangitis. Other inflammatory conditions of the CBD which are potential etiological factors included bacteria or virus infection, parasite infestation, abdominal trauma, congenital abnormality[14], chronic pancreatitis[15], inflammatory pseudotumors[16], complication of chemotherapy[17], complication of duodenal ulcer disease[18-20], and sclerosing therapy of bleeding duodenal ulcer[21]. Most benign segmental strictures of the extra-hepatic bile duct reported in the literature were located at the hilum or distal CBD. Few cases in the mid CBD have been reported.

The CBD strictures of these 2 patients were less likely due to biliary duct stones because the radiological studies and operative findings did not show the existence of stones. The normal pancreatogram excluded the possibility of chronic pancreatitis as the cause of mid CBD strictures. The radiological appearance, histological examination and the extremely rare incidence in this area made the diagnosis of primary sclerosing cholangitis less likely.

According to the clinical history and surgical findings, stricture of the CBD owing to fibrous encasement by chronic inflammatory changes due to an adjacent duodenal ulcer in these 2 cases was considered. Duodenal ulcer disease is a common disorder, and its associated complications such as hemorrhage, gastric outlet obstruction and perforation, are well known. However, the biliary complications of duodenal ulcer disease, such as biliary-enteric fistula or partial obstruction of the CBD were rare and less well-known[18-20], especially after the worldwide use of effective antisecretory agents, H2-receptor antagonists and proton pump inhibitors.

In conclusion, benign non-traumatic inflammatory strictures affecting the common bile duct can be mistaken for malignant tumors. Their existence should be considered in the differential diagnosis of any biliary strictures. The radiological documentation of these 2 cases is of interest to draw attention to the rare complication of obstructive jaundice secondary to duodenal ulcer disease. A tissue diagnosis should be obtained whenever possible as radiology alone is often insufficient to make a firm diagnosis of malignancy in biliary strictures.

Footnotes

Edited by Wang XL Proofread by Chen WW and Xu FM

References
1.  Golematis B, Giannopoulos A, Papchristou DN, Dreiling DA. Sclerosing cholangitis of the bifurcation of the common hepatic duct. Am J Gastroenterol. 1981;75:370-372.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Smadja C, Bowley NB, Benjamin IS, Blumgart LH. Idiopathic localized bile duct strictures: relationship to primary sclerosing cholangitis. Am J Surg. 1983;146:404-408.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 19]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
3.  Panés J, Bordas JM, Bruguera M, Cortés M, Rodés J. Localized sclerosing cholangitis. Endoscopy. 1985;17:121-122.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
4.  Gerhards MF, Vos P, van Gulik TM, Rauws EA, Bosma A, Gouma DJ. Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg. 2001;88:48-51.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 139]  [Cited by in F6Publishing: 149]  [Article Influence: 6.5]  [Reference Citation Analysis (0)]
5.  Longmire WP, McArthur MS, Bastounis EA, Hiatt J. Carcinoma of the extrahepatic biliary tract. Ann Surg. 1973;178:333-345.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 142]  [Cited by in F6Publishing: 157]  [Article Influence: 3.1]  [Reference Citation Analysis (0)]
6.  Feydy A, Vilgrain V, Denys A, Sibert A, Belghiti J, Vullierme MP, Menu Y. Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. AJR Am J Roentgenol. 1999;172:73-77.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 76]  [Cited by in F6Publishing: 79]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
7.  Choi BI, Han JK, Shin YM, Baek SY, Han MC. Peripheral cholangiocarcinoma: comparison of MRI with CT. Abdom Imaging. 1995;20:357-360.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 41]  [Cited by in F6Publishing: 43]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
8.  Rabinovitz M, Zajko AB, Hassanein T, Shetty B, Bron KM, Schade RR, Gavaler JS, Block G, Van Thiel DH, Dekker A. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures. Hepatology. 1990;12:747-752.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 139]  [Cited by in F6Publishing: 140]  [Article Influence: 4.1]  [Reference Citation Analysis (0)]
9.  Rustgi AK, Kelsey PB, Guelrud M, Saini S, Schapiro RH. Malignant tumors of the bile ducts: diagnosis by biopsy during endoscopic cannulation. Gastrointest Endosc. 1989;35:248-251.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 40]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
10.  Terasaki K, Wittich GR, Lycke G, Walter R, Nowels K, Swanson D, Lucas D. Percutaneous transluminal biopsy of biliary strictures with a bioptome. AJR Am J Roentgenol. 1991;156:77-78.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 20]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
11.  Cope C, Marinelli DL, Weinstein JK. Transcatheter biopsy of lesions obstructing the bile ducts. Radiology. 1988;169:555-556.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 14]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
12.  Andersson R, Andrén-Sandberg A, Lundstedt C, Tranberg KG. Implantation metastases from gastrointestinal cancer after percutaneous puncture or biliary drainage. Eur J Surg. 1996;162:551-554.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Standfield NJ, Salisbury JR, Howard ER. Benign non-traumatic inflammatory strictures of the extrahepatic biliary system. Br J Surg. 1989;76:849-852.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 35]  [Cited by in F6Publishing: 34]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
14.  Baggott BB, Long WB. Annular pancreas as a cause of extrahepatic biliary obstruction. Am J Gastroenterol. 1991;86:224-226.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Littenberg G, Afroudakis A, Kaplowitz N. Common bile duct stenosis from chronic pancreatitis: a clinical and pathologic spectrum. Medicine (Baltimore). 1979;58:385-412.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 51]  [Cited by in F6Publishing: 51]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
16.  Hadjis NS, Collier NA, Blumgart LH. Malignant masquerade at the hilum of the liver. Br J Surg. 1985;72:659-661.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 96]  [Cited by in F6Publishing: 98]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
17.  Herrmann G, Lorenz M, Kirkowa-Reimann M, Hottenrott C, Hübner K. Morphological changes after intra-arterial chemotherapy of the liver. Hepatogastroenterology. 1987;34:5-9.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  NEIMAN JH. Obstructive jaundice caused by duodenal ulcer. J Am Med Assoc. 1953;152:141.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 4]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
19.  Glick S. Benign non-traumatic stricture of the common bile-duct owing to penetrating duodenal ulcer. Br J Surg. 1971;58:918-920.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 3]  [Article Influence: 0.1]  [Reference Citation Analysis (0)]
20.  Fuller JW, Christensen JA, Sherman RT. Common bile duct obstruction secondary to peptic ulcer. Am Surg. 1975;41:640-642.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Luman W, Hudson N, Choudari CP, Eastwood MA, Palmer KR. Distal biliary stricture as a complication of sclerosant injection for bleeding duodenal ulcer. Gut. 1994;35:1665-1667.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 15]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]